Skip to main content Help with accessibility Skip to main navigation

Adalimumab

Indication

Non-radiographic axial spondyloarthritis (NICE TA383)

NICE TA383 - TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis

 

Red

Brand:

Humira®

Nice TA:

383

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Musculoskeletal system

Background

Adalimumab is recommended, within its marketing authorisations, as an option for treating severe non-radiographic axial spondyloarthritis in adults whose disease has responded inadequately to, or who cannot tolerate, non‑steroidal anti‑inflammatory drugs.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Decisions of Lancashire local decision making groups

Red
Red
Red
Red
Red
Red
Red
Red
What do the colours mean?

Last Updated: 01 - Mar - 2016